Pharmacielo Stock Net Income
| PCLOF Stock | USD 0.06 0.01 12.61% |
As of the 29th of January, Pharmacielo holds the Coefficient Of Variation of 725.34, semi deviation of 13.1, and Risk Adjusted Performance of 0.1112. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pharmacielo, as well as the relationship between them. Please check Pharmacielo coefficient of variation and the relationship between the jensen alpha and skewness to decide if Pharmacielo is priced some-what accurately, providing market reflects its current price of 0.0603 per share. As Pharmacielo appears to be a penny stock we also advise to check out its total risk alpha numbers.
Pharmacielo's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Pharmacielo's valuation are provided below:Pharmacielo does not presently have any trending fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Pharmacielo |
Pharmacielo 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pharmacielo's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pharmacielo.
| 10/31/2025 |
| 01/29/2026 |
If you would invest 0.00 in Pharmacielo on October 31, 2025 and sell it all today you would earn a total of 0.00 from holding Pharmacielo or generate 0.0% return on investment in Pharmacielo over 90 days. Pharmacielo is related to or competes with Avant Brands. PharmaCielo Ltd., together with its subsidiary, cultivates, processes, produces, and supplies medicinal-grade cannabis e... More
Pharmacielo Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pharmacielo's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pharmacielo upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 18.56 | |||
| Information Ratio | 0.1359 | |||
| Maximum Drawdown | 290.0 | |||
| Value At Risk | (20.69) | |||
| Potential Upside | 41.67 |
Pharmacielo Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pharmacielo's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pharmacielo's standard deviation. In reality, there are many statistical measures that can use Pharmacielo historical prices to predict the future Pharmacielo's volatility.| Risk Adjusted Performance | 0.1112 | |||
| Jensen Alpha | 5.1 | |||
| Total Risk Alpha | 1.88 | |||
| Sortino Ratio | 0.2792 | |||
| Treynor Ratio | 2.3 |
Pharmacielo January 29, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1112 | |||
| Market Risk Adjusted Performance | 2.31 | |||
| Mean Deviation | 18.19 | |||
| Semi Deviation | 13.1 | |||
| Downside Deviation | 18.56 | |||
| Coefficient Of Variation | 725.34 | |||
| Standard Deviation | 38.13 | |||
| Variance | 1454.0 | |||
| Information Ratio | 0.1359 | |||
| Jensen Alpha | 5.1 | |||
| Total Risk Alpha | 1.88 | |||
| Sortino Ratio | 0.2792 | |||
| Treynor Ratio | 2.3 | |||
| Maximum Drawdown | 290.0 | |||
| Value At Risk | (20.69) | |||
| Potential Upside | 41.67 | |||
| Downside Variance | 344.48 | |||
| Semi Variance | 171.54 | |||
| Expected Short fall | (33.65) | |||
| Skewness | 5.33 | |||
| Kurtosis | 36.46 |
Pharmacielo Backtested Returns
Pharmacielo is out of control given 3 months investment horizon. Pharmacielo maintains Sharpe Ratio (i.e., Efficiency) of 0.14, which implies the firm had a 0.14 % return per unit of risk over the last 3 months. We were able to break down and interpolate data for twenty-seven different technical indicators, which can help you to evaluate if expected returns of 5.68% are justified by taking the suggested risk. Use Pharmacielo Semi Deviation of 13.1, coefficient of variation of 725.34, and Risk Adjusted Performance of 0.1112 to evaluate company specific risk that cannot be diversified away. Pharmacielo holds a performance score of 11 on a scale of zero to a hundred. The company holds a Beta of 2.28, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Pharmacielo will likely underperform. Use Pharmacielo coefficient of variation, potential upside, day typical price, as well as the relationship between the sortino ratio and skewness , to analyze future returns on Pharmacielo.
Auto-correlation | 0.09 |
Virtually no predictability
Pharmacielo has virtually no predictability. Overlapping area represents the amount of predictability between Pharmacielo time series from 31st of October 2025 to 15th of December 2025 and 15th of December 2025 to 29th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pharmacielo price movement. The serial correlation of 0.09 indicates that less than 9.0% of current Pharmacielo price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.09 | |
| Spearman Rank Test | 0.44 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Pharmacielo reported net income of (26.63 Million). This is 107.8% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The net income for all United States stocks is 104.66% higher than that of the company.
Pharmacielo Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pharmacielo's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Pharmacielo could also be used in its relative valuation, which is a method of valuing Pharmacielo by comparing valuation metrics of similar companies.Pharmacielo is currently under evaluation in net income category among its peers.
Pharmacielo Fundamentals
| Return On Equity | -0.98 | |||
| Return On Asset | -0.26 | |||
| Operating Margin | (3.22) % | |||
| Current Valuation | 38.68 M | |||
| Shares Outstanding | 151.41 M | |||
| Shares Owned By Insiders | 3.50 % | |||
| Shares Owned By Institutions | 5.71 % | |||
| Price To Book | 4.28 X | |||
| Price To Sales | 7.25 X | |||
| Revenue | 1.94 M | |||
| Gross Profit | (4.17 M) | |||
| EBITDA | (24.75 M) | |||
| Net Income | (26.63 M) | |||
| Cash And Equivalents | 1.17 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 7.14 M | |||
| Debt To Equity | 0.70 % | |||
| Current Ratio | 0.81 X | |||
| Book Value Per Share | 0.06 X | |||
| Cash Flow From Operations | (20.07 M) | |||
| Earnings Per Share | (0.12) X | |||
| Beta | 2.85 | |||
| Market Capitalization | 31.8 M | |||
| Total Asset | 35.96 M | |||
| Z Score | 2.4 | |||
| Net Asset | 35.96 M |
About Pharmacielo Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pharmacielo's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pharmacielo using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pharmacielo based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Pharmacielo Pink Sheet
Pharmacielo financial ratios help investors to determine whether Pharmacielo Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmacielo with respect to the benefits of owning Pharmacielo security.